CheckMan Stock Market Overview
Trending Stocks
Red List
In Today's Headlines
Consumer staples and Dividend Kings like PepsiCo NASDAQ: PEP are not often stocks that provide a lot of PEP for a portfolio. However, they can deliver substantial, market-beating returns when the stars align.
MSCI (MSCI) came out with quarterly earnings of $3.52 per share, beating the Zacks Consensus Estimate of $3.44 per share. This compares to earnings of $3.14 per share a year ago.
Quest Diagnostics (DGX) came out with quarterly earnings of $2.04 per share, beating the Zacks Consensus Estimate of $1.86 per share. This compares to earnings of $2.04 per share a year ago.
United Parcel Service (UPS) on Tuesday released first-quarter results that surpassed analyst expectations for adjusted profit but fell short of revenue expectations.
Market volatility has returned and could persist with our ongoing macroeconomic and geopolitical risks. JEPQ offers an effective hedge against such volatility. Its dividend yield of 9.5% provides current income and downside protection.
The House of Representatives passed legislation over the weekend that would broaden sanctions against Iran's oil exports
Primark owner Associated British Foods PLC (LSE:ABF)'s exceptionally strong set of financial results has provided a much-needed sentiment boost for the London stock market. It wasn't just cornerstone asset Primark driving profits; the group's grocery segment grew operating profits by a chunky 34%, while the ingredients division grew by 16%.
One analyst sees a number of potential upside catalysts when Alphabet reports first quarter results later this week. Cost cutting, a potential dividend, and a new CFO candidate could each propel the stock higher.
Tiziana Life Sciences Ltd (NASDAQ:TLSA) announced that it has been approved by the US Food and Drug Administration to expand patient enrollment in its non-active Secondary Progressive Multiple Sclerosis (na-SPMS) Expanded Access Program. The company said it will expand the program, which is evaluating its investigative therapeutic intranasal foralumab, from 10 patients to 30.
The gold market has drifted lower again in the early hours of Tuesday, as we continue to see the idea of a widening war in the Middle East disappear, at least for now. However, there are other reasons to think that the gold market could find buyers eventually.